| Line Item | Jun 30, 2026 | Mar 31, 2026 | Jun 30, 2025 | Mar 31, 2025 |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenues | ||||
| Gross profit | ||||
| % of revenue | 24.0% | 19.0% | ||
| Operating expenses | ||||
| Selling, general and administrative expenses | ||||
| Stock-based compensation expense | ||||
| Research and development | ||||
| Transaction costs | ||||
| Total operating expenses | ||||
| % of revenue | 68.6% | 114.0% | ||
| Loss from operations | ||||
| % of revenue | -44.6% | -94.9% | ||
| Other (expense) income | ||||
| Interest expense | ||||
| Interest income | ||||
| Other (expense) income, net | ||||
| Total other income (expense) | ||||
| Loss before provision for income taxes | ||||
| Income tax (expense) benefit | ||||
| Net loss | ||||
| % of revenue | -42.5% | -98.7% | ||
| Net loss | ||||
| % of revenue | -42.5% | -98.7% | ||
| Net loss available to common shareholders | ||||
| Net loss available to common shareholders, basic net loss per share (in dollars per share) | ||||
| Net loss available to common shareholders, diluted net loss per share (in usd per share) |